Tiziana life sciences to host investor call

New york, nov. 04, 2022 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the company plans to host an investor call and webcast on thursday, november 10 2022 at 10 a.m. et.
TLSA Ratings Summary
TLSA Quant Ranking